About | Free Trial

Last Update

2015-09-08T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong J. McGovren?

Dr. J. McGovren Patrick

Scientific Advisory Board Member

RealBio Technology Inc

HQ Phone: (269) 544-1088

Email: j***@***.com

RealBio Technology Inc

4717 Campus Drive Suite 1500

Kalamazoo, Michigan 49008

United States

Find other employees at this company (2)

Background Information

Employment History

Principal
J Patrick McGovren LLC

Vice President, Preclinical Development
ProNAi Therapeutics , Inc.

Chief Scientific Officer
AzoRx , Inc.

Vice President
Preclinical Development

Clinical Research Manager, Oncology Medical Affairs
Pharmacia & Upjohn

Numerous Senior Research and Management Posts
Pharmacia & Upjohn

Clinical Operations Manager for Phase IV and Post-Marketing Studies
Pharmacia & Upjohn

Affiliations

Member of Scientific Advisory Board
ProNAi Therapeutics , Inc.

Board Member
AzoRx , Inc.

Scientific Advisory Board Member
AzoRx , Inc.

Education

Ph.D.

PhD

Web References (13 Total References)


RealBio® - Learn More Information About RealBio® Technology, Inc.

www.realbiotechnology.com [cached]

J. Patrick McGovren, Ph.D.

Dr. McGovren has a Ph.D. in Pharmaceutical Sciences and extensive pharmaceutical industry and start-up experience in the preclinical and clinical development of anticancer drugs. He was deeply involved in the discovery and/or development of 10 clinically evaluated antitumor drugs. Pat was a key advocate for The Upjohn Company's successful in-licensing of irinotecan which was marketed as Camptosarâ„¢ Injection and became a significant colorectal cancer product with $500 MM per annum US sales. During his laboratory career, Dr. McGovren was responsible for screening and detailed evaluation of test compounds in mouse tumor models as well as the preclinical pharmacology and pharmacokinetics of lead compounds. Later he worked as a clinical operations manager for phase IV/post-marketing studies, and then moved into Pharmacia's clinical pharmacology group. He has prepared IND and NDA preclinical and clinical pharmacology sections and participated in resolving numerous clinical pharmacology-related regulatory issues.


ProNAi Therapeutics - Employing DNA to Silence Disease

www.pronai.com [cached]

Patrick McGovren, PhDPrincipal, J. Patrick McGovren LLC, Kalamazoo, MI, Research Director, Clinical Pharmacology, Medical Development, Pfizer Corporation and past Clinical Research Manager, Oncology Medical Affairs, Pharmacia Corporation


Scientific Advisory Board

www.AzoRx.com [cached]

J. Patrick McGovren, Ph.D.

Chief Scientific Officer AzoRx, Inc.


J. Patrick McGovren, ...

www.AzoRx.com [cached]

J. Patrick McGovren, Ph.D..

Chief Scientific OfficerAzoRx, Inc.


ProNAi Therapeutics - Employing DNA to Silence Disease

www.pronai.com [cached]

Dr. J. Patrick McGovren, Vice President of Preclinical Development

...
Dr. J. Patrick McGovren, VP, Preclinical Development - Dr. McGovren is a longtime and well-known cancer research specialist, holding senior positions in big pharma oncology departments, as well as extensive consulting experience. Prior to joining ProNAi, Dr. McGovren was most recently Research Director, Clinical Pharmacology, Medical Development at Pfizer, following a term as Clinical Research Manager, Oncology Medical Affairs at Pharmacia. Between 1976 and 2000, Dr. McGovren held numerous senior research and management positions at Pharmacia & Upjohn.

Similar Profiles

Other People with this Name

Other people with the name McGovren

Matt McGovren
Wink.com

Kathryn McGovren
PharmaNet/i3

Shea McGovren
METHODIST SPORTS MEDICINE CENTER P.C

John McGovren
Jasper Engines

Pat McGovren
J Patrick McGovren LLC

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory